Ledger.Open graph →

SEC Form D · Amendment · filed March 13, 2017

Tocagen Inc

Offering

$13.0M

Sold

$10.9M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (29)

Harry Gruber · San Diego, CAExec · Director Paul R. Schimmel · San Diego, CADirector Lori R. Kunkel · San Diego, CADirector David R. Parkinson · San Diego, CADirector Thomas Darcy · San Diego, CAExec · Director Franklin M. Berger · San Diego, CADirector Dennis Berman · San Diego, CAExec · Director Martin J. Duvall · San Diego, CAExec · Director Douglas Jolly · San Diego, CAExec Faheem M. Hasnain · San Diego, CADirector Michael A. Okaty · Orlando, FLDirector Victory Road Investors, LLC · North Quincy, MADirector Maxwell E. A · Maitland, FLExec Rick H. Walsh · Orlando, FLExec · Director William J. Anderson · Toronto, Ontario, Z4Director Terrence R. Gleason · Lake Havasu City, AZExec · Director Morey H. Goldberg · Wynnewood, PADirector Mark J. Foletta · San Diego, CAExec Terry Girling · Nassau, C5Director Renato A. Mazzolini · Nassau, C5Exec · Director Barry Lieberman · Santa Barbara, CAExec · Director Eli Aizenstat · Santa Barbara, CAExec · Director David J. Blumberg · San Francisco, CADirector Mark A. Allen · Cambridge, MADirector Jenny Abramson · White Plains, NYExec · Director Christopher A. Mccain · Cambridge, MAExec · Director Steve C. Owen · Austin, TXDirector Pareed R. Aliyar · Lake Havasu City, AZExec · Director Mark J. Foletta · San Diego, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗